Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Desonide
Drug ID BADD_D00619
Description A nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatose.
Marketing Status approved; investigational
ATC Code D07AB08; S01BA11
DrugBank ID DB01260
KEGG ID D03696
MeSH ID D003898
PubChem ID 5311066
TTD Drug ID D02JNM
NDC Product Code 0713-0661; 15308-0713; 51508-009; 51552-1616; 62332-550; 22552-0046; 50436-3300; 51672-4079; 16110-111; 63629-8739; 62332-485; 72578-086; 0168-0309; 44118-710; 62332-632; 63187-747; 63629-2507; 0472-0803; 52128-157; 16714-828; 0472-0804; 0299-5770; 16714-729; 45802-422; 45802-423; 0299-5765; 63629-2506; 46439-8713; 24470-920; 51672-1281; 52187-556; 38779-3043; 70771-1381; 0168-0310; 51672-1280
UNII J280872D1O
Synonyms Desonide | Prednacinolone | Tridésonit | Locapred | Locatop | Tridesilon | Desone | Desowen | Desocort
Chemical Information
Molecular Formula C24H32O6
CAS Registry Number 638-94-8
SMILES CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site atrophy12.07.01.037; 08.02.01.037--Not Available
Application site erythema23.03.06.005; 12.07.01.001; 08.02.01.001--Not Available
Application site irritation12.07.01.003; 08.02.01.003--Not Available
Application site pain12.07.01.004; 08.02.01.004--Not Available
Application site pruritus23.03.12.004; 12.07.01.005; 08.02.01.005--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Atrophy08.03.04.001--Not Available
Blood pressure increased13.14.03.005--Not Available
Burning sensation08.01.09.029; 17.02.06.001--Not Available
Cough22.02.03.001--
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis11.02.01.053; 23.11.04.003--
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Infection11.01.08.002--Not Available
Irritability19.04.02.013; 08.01.03.011--
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Pain08.01.08.004--
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Rash pustular23.03.10.003; 11.01.12.002--
The 1th Page    1 2    Next   Last    Total 2 Pages